THE WALL STREET TRANSCRIPT PUBLISHES SPECIALTY PHARMACEUTICALS ISSUE BUSINESS EDITORS & HEALTH/MEDICAL WRITERS BIOWIRE2K NEW YORK--(BW HEALTHWIRE)--AUG. 6, 2001--SIX ANALYSTS, TWO EXPERTS INTERVIEWS
NEW YORK--(BW HealthWire)--Aug. 6, 2001--Six analysts, two experts
interviews and top management from twenty-four sector firms examine
the Specialty Pharmaceuticals sector in this special 134-page issue
from The Wall Street Transcript (212/952-7433) or
twst.com.
In a vital review of this sector for investors and industry
professionals, this valuable 134-page Special Issue features:
1) Specialty Pharmaceuticals -- In an in-depth (12,700 words)
Analyst Roundtable, Timothy Anderson, Analyst covering the Specialty
Pharmaceuticals and Drug Delivery sectors at Prudential Securities,
Erick Lucera, Analyst at CJS Capital Management, LLC, Ian Sanderson,
Managing Director at SG Cowen, Richard Silver, Senior Vice President
at Lehman Brothers and Jerry Treppel, Managing Director with Banc of
America Securities LLC, examine the outlook for the sector and share
specific stock recommendations.
Silver reports, "Teva (Nasdaq:TEVA.Q) probably stands out as being the most successful with an aggressive generic acquisition strategy on a global basis, demonstrating that generics can fuel long-term growth
if the acquisition targets make sense and as long as post acquisition integration capabilities are strong."
2) Drug Delivery Stocks -- In an in-depth (4,000 words) Analyst
Interview, Louis Webb, Jr., Principal with Dain Rauscher Wessels,
examines the outlook for the sector and shares specific stock
recommendations.
3) Intersecting with Specialty Pharmaceuticals -- In an in-depth
(3,300 words) Expert Interview, John Rhodes, Managing Partner for
Pharmaceuticals and Life Sciences at Deloitte & Touche, examines the
outlook for the sector and shares specific stock recommendations.
4) Executive Search for Pharmaceutical Companies -- In an in-depth
(2,800 words) Expert Interview, Robert Hennessy, Managing Director at
Hennessy Group, examines the outlook for the sector and shares
specific stock recommendations.
5) The TWST confidential Off-The-Record survey of management
performance at seventeen sector firms asked market insiders about the
ability of management teams to create shareholder value.
6) CEO interviews (average 2,500 words). Top management of
twenty-four sector firms examine the outlook for their firm and the
sector.
To obtain the CEO interviews/Off-The-Record management performance
full interview report, see twst.com.
The Wall Street Transcript does not endorse the views of any
interviewee nor does it make stock recommendations.
--30--jlp/clv* |
